Facebook Linkedin RSS Twitter Youtube
Home 2022

FDA review

Synthesis of Bacterium’s Anticancer Warhead Described
Cancer

Synthesis of Bacterium’s Anticancer Warhead Described

Busy Bees: Hexagon Bio Combs Nature’s DNA to Unlock Next-Gen Medicines
Cancer

Busy Bees: Hexagon Bio Combs Nature’s DNA to Unlock Next-Gen Medicines

FDA Rejects Reata’s Application for Chronic Kidney Disease Drug
Drug Discovery

FDA Rejects Reata’s Application for Chronic Kidney Disease Drug

Ischemic Stroke Damage Reduced by Inter-α Inhibitor Proteins
News

Ischemic Stroke Damage Reduced by Inter-α Inhibitor Proteins

Pfizer-BioNTech COVID-19 Vaccine Gains Full FDA Approval
Coronavirus

Pfizer-BioNTech COVID-19 Vaccine Gains Full FDA Approval

Cancerous Blood Cells Tip the Balance from Death to Growth, New Discoveries Reveal
Cancer

Cancerous Blood Cells Tip the Balance from Death to Growth, New Discoveries Reveal

Regeneron Plans 1,000 New Jobs in $1.8B HQ Expansion
News

Regeneron Plans 1,000 New Jobs in $1.8B HQ Expansion

Accelerating the Development of Curative Medicines with Functional Immune Profiling
eBooks

Accelerating the Development of Curative Medicines with Functional Immune Profiling

Novavax Plans FDA Filing for COVID-19 Vaccine after Positive Efficacy Data
Coronavirus

Novavax Plans FDA Filing for COVID-19 Vaccine after Positive Efficacy Data

FDA Authorizes Emergency Use of J&J’s Single-Shot COVID-19 Vaccine
Coronavirus

FDA Authorizes Emergency Use of J&J’s Single-Shot COVID-19 Vaccine

123...10Page 2 of 10
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.